Olanzapine 10 mg tablets recalled due to cGMP deviations
Macleods Pharma USA is voluntarily recalling Olanzapine 10 mg tablets nationwide due to cGMP (current good manufacturing practices) deviations identified during manufacturing. The recall affects 3,672 bottles distributed across the United States.
- Product
- OLANZAPINE — OLANZAPINE (OLANZAPINE)
- Category
- Drug
- Distribution
- Distributed nationwide